Top Clinical Trials companies in Saudi Arabia by Price to Sales Ratio (P/S)
Saudi Arabia
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
2.37 |
Feb. 10, 2025 | USD 8.71 | -0.52% |
|
Saudi Arabia |
Frequently Asked Questions
-
Which Clinical Trials company in Saudi Arabia has the highest Price to Sales Ratio (P/S) ?
The Clinical Trials company in Saudi Arabia with the highest Price to Sales Ratio (P/S) is Saudi Pharmaceutical Industries and Medical Appliances Corporation (Saudi Stock Exchange: 2070.SR) at 2.37.
-
Which Clinical Trials company in Saudi Arabia has the lowest Price to Sales Ratio (P/S) ?
The Clinical Trials company in Saudi Arabia with the lowest Price to Sales Ratio (P/S) is Saudi Pharmaceutical Industries and Medical Appliances Corporation (Saudi Stock Exchange: 2070.SR) at 2.37.
-
What are the top 10 Clinical Trials companies in Saudi Arabia by Price to Sales Ratio (P/S) ?
The top 10 Clinical Trials companies in Saudi Arabia by Price to Sales Ratio (P/S) are and Saudi Pharmaceutical Industries and Medical Appliances Corporation.
-
What are the bottom 10 Clinical Trials companies in Saudi Arabia by Price to Sales Ratio (P/S) ?
The bottom 10 Clinical Trials companies in Saudi Arabia by Price to Sales Ratio (P/S) are and Saudi Pharmaceutical Industries and Medical Appliances Corporation.
